7 reports of this reaction
2.0% of all PECTIN reports
#8 most reported adverse reaction
ASTHENIA is the #8 most commonly reported adverse reaction for PECTIN, manufactured by Mondelez Global LLC. There are 7 FDA adverse event reports linking PECTIN to ASTHENIA. This represents approximately 2.0% of all 356 adverse event reports for this drug.
Patients taking PECTIN who experience asthenia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ASTHENIA is a less commonly reported adverse event for PECTIN, but still significant enough to appear in the safety profile.
In addition to asthenia, the following adverse reactions have been reported for PECTIN:
The following drugs have also been linked to asthenia in FDA adverse event reports:
ASTHENIA has been reported as an adverse event in 7 FDA reports for PECTIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
ASTHENIA accounts for approximately 2.0% of all adverse event reports for PECTIN, making it a notable side effect.
If you experience asthenia while taking PECTIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.